OI Onco-Innovations Limited Stock: price and directors' dealings · Canada · SEDIFollow the Onco-Innovations Limited share price and the full management transaction log of the company, a listed issuer based in Canada. Shares are quoted on the CA market, under the authority of SEDI. Operating in the Health Care sector, Onco-Innovations Limited has logged 37 public disclosures. Market capitalisation: €40.3m. The latest transaction was disclosed on 19 August 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Mohamed, Islam G.. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 August 2026
All Executives37 Thresholds0 Prospectus0 Other0
Declarations 37 total
▲ 5 - Senior Officer of Issuer · Executives · 17 Aug 2026
11,000 shares @ CA$0.65 Common Shares SEDI:4766539 Canonical exit: 15 Nov 2026 (T+90) ● 5 - Senior Officer of Issuer · Executives · 17 Aug 2026
16,666 shares Rights SEDI:4766272 ● 5 - Senior Officer of Issuer · Executives · 17 Aug 2026
16,666 shares Common Shares SEDI:4766271 ● 5 - Senior Officer of Issuer · Executives · 5 Jun 2026
Common Shares SEDI:4766270 ● 4 - Director of Issuer · Executives · 17 Aug 2026
20,000 shares Rights SEDI:4766123 ● 4 - Director of Issuer · Executives · 17 Aug 2026
20,000 shares Common Shares SEDI:4766121 ● 5 - Senior Officer of Issuer · Executives · 17 Aug 2026
33,333 shares Common Shares SEDI:4765945 ● 5 - Senior Officer of Issuer · Executives · 17 Aug 2026
33,333 shares Rights SEDI:4765944 ● 4 - Director of Issuer · Executives · 17 Aug 2026
50,000 shares Common Shares SEDI:4765943 ● 4 - Director of Issuer · Executives · 26 Nov 2024
Common Shares SEDI:4765941 ● 4 - Director of Issuer · Executives · 17 Aug 2026
50,000 shares Rights SEDI:4765940 ● 5 - Senior Officer of Issuer · Executives · 17 Aug 2026
16,666 shares Common Shares SEDI:4765939 ● 5 - Senior Officer of Issuer · Executives · 17 Aug 2026
16,666 shares Rights SEDI:4765938 ● 4 - Director of Issuer · Executives · 17 Aug 2026
50,000 shares Common Shares SEDI:4765934 ● 4 - Director of Issuer · Executives · 26 Nov 2024
Common Shares SEDI:4765933 ● 4 - Director of Issuer · Executives · 17 Aug 2026
50,000 shares Rights SEDI:4765932 ● 5 - Senior Officer of Issuer · Executives · 17 Aug 2026
150,000 shares Common Shares SEDI:4765928 ● 5 - Senior Officer of Issuer · Executives · 17 Aug 2026
150,000 shares Rights SEDI:4765926 ▲ 5 - Senior Officer of Issuer · Executives · 13 Aug 2026
26,000 shares @ CA$0.55 0.041% mcap 100.0% of flow Common Shares SEDI:4764232 Canonical exit: 11 Nov 2026 (T+90) ● 5 - Senior Officer of Issuer · Executives · 15 Jul 2026
62,500 shares Common Shares SEDI:4753162 ● 5 - Senior Officer of Issuer · Executives · 15 Jul 2026
62,500 shares Rights SEDI:4753161 ● 5 - Senior Officer of Issuer · Executives · 17 Apr 2026
Common Shares SEDI:4753160 ● 5 - Senior Officer of Issuer · Executives · 17 Apr 2026
● 5 - Senior Officer of Issuer · Executives · 15 Jul 2026
6,250 shares Common Shares SEDI:4753157 ● 5 - Senior Officer of Issuer · Executives · 15 Jul 2026
6,250 shares Rights SEDI:4753155 25 of 37 declarations
Load more (12 remaining) About Onco-Innovations Limited Onco-Innovations Limited is a company focused on developing innovative cancer treatments. It is listed on the XTSE market.